尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the detailed record of transactions filed by Patterson Sandra. Officer active across 1 company, notably Gilead Sciences, INC.. In total, 13 disclosures have been published. Activity tracked since 4 February 2025. The latest transaction was disclosed on 4 February 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 条申报中的 13 条
Sandra Patterson is a declarant with 13 filings in total. The 13 sampled filings, from 2023-03-13 to 2025-03-12, concern Gilead Sciences, INC., and the listed role is SVP, Controllership. The most common transaction type is Option exercise, and the aggregated buy and sell amounts for the recent sampled filings are EUR 0 and EUR 0.